👥 HR & Workplace🇮🇳 India
ChrysCapital Takes Control of Novartis India and Installs New CEO
Mint·Thursday, 30 July 2026
Private equity firm ChrysCapital has acquired a controlling stake in Novartis India, marking its first majority-controlled investment in the Indian pharmaceutical sector. A new CEO has been appointed as part of the transition. This is a significant ownership change for one of India's well-known pharma companies.
Why It Matters
Novartis India operates across the country's healthcare market. A change in ownership and leadership could affect employees, drug availability, and how the company operates going forward.
🔒 Potential Impact + source link
Subscribe to unlock the impact analysis and original source for every story.
More from HR & Workplace
- Cognizant Beats TCS and Infosys but Cuts Its Own Growth Forecast — What That Means for Indian IT
- AI Is Changing What HR Professionals Actually Do at Work, OpenAI Report Finds
- Most Managers Feel Unprepared to Lead Teams That Use AI, New Research Shows
- Fiverr's Stock Crashes, Showing in Real Time How AI Is Hurting Freelance Workers